NCT00004070 2017-04-20Gene Therapy in Treating Patients With Unresectable, Recurrent, or Refractory Head and Neck CancerDana-Farber Cancer InstitutePhase 1/2 Completed7 enrolled
NCT00004074 2013-02-28Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuNational Cancer Institute (NCI)Phase 1 Completed15 enrolled